OpenLobby.EU

France Assos Santé

France Assos Santé est le nom choisi par l’Union nationale des associations agréées d’usagers du système de santé afin de faire connaître son action comme organisation de référence pour représenter les patients et les usagers du système de santé et défendre leurs intérêts.

Lobbying Activity

Meeting with Tiemo Wölken (Member of the European Parliament, Shadow rapporteur) and European Society for Medical Oncology (ESMO)

15 Jul 2025 · Critical Medicines Act

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL laying a framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest, and amending Regulation (EU) 2024/795

2 Jul 2025

Response to COMMISSION IMPLEMENTING REGULATION (EU) …/... laying down rules for the application of Regulation (EU) 2021/2282 with regard to the procedures for joint scientific consultations on medicinal products for human use at Union level

28 Oct 2024

Meeting with Pierre Jouvet (Member of the European Parliament) and European Patients' Forum (EPF)

15 Oct 2024 · Politiques de santé

Meeting with Christophe Clergeau (Member of the European Parliament)

20 Sept 2024 · Santé

Response to COMMISSION IMPLEMENTING REGULATION (EU) …/... laying down rules for the application of Regulation (EU) 2021/2282 of the European Parliament and of the Council as regards the management of conflicts of interest in the joint work of the Member State Coordination Group on Health Technology Assessment and its subgroups

25 Jun 2024

Meeting with François Thiollet (Member of the European Parliament)

17 Apr 2024 · Echance politique Occitanie

Response to COMMISSION IMPLEMENTING REGULATION (EU) …/... laying down, pursuant to Regulation (EU) 2021/2282 on health technology assessment, procedural rules for the interaction during, exchange of information on, and participation in, the preparation and update of joint clinical assessments of medicinal products for human use at Union level, as well as templates for those joint clinical assessments

2 Apr 2024

Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur) and Biogen

16 Feb 2024 · Directive on Medicinal products for human use

Meeting with Tilly Metz (Member of the European Parliament) and

10 Oct 2023 · Pharma Package

Meeting with Catherine Amalric (Member of the European Parliament, Shadow rapporteur) and

18 Sept 2023 · Reform of the EU pharmaceutical legislation

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL laying down Union procedures for the authorisation and supervision of medicinal products for human use and establishing rules governing the European Medicines Agency, amending Regulation (EC) No 1394/2007 and Regulation (EU) No 536/2014 and repealing Regulation (EC) No 726/2004, Regulation (EC) No 141/2000 and Regulation (EC) No 1901/2006

27 Jul 2023

Response to Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on liability for defective products

9 Dec 2022

Response to Proposal for a Directive adapting liability rules to the digital age and Artificial Intelligence

27 Jul 2021